News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-04-06-2016
Volume11
Issue 4

Sartorius Stedim BioOutsource Contract Testing Facility in Glasgow Passes FDA Inspection

The inspection confirmed that the facility was compliant with GMP guidelines.

Sartorius Stedim BioOutsource, a subsidiary of Sartorius Stedim Biotech, announced on March 2, 2016 that its Glasgow facility passed FDA inspection.

According to the company, the FDA compliance safety office spent two days at the facility, reviewing its quality systems and their application to the analytical services that support the testing of biologics, vaccines, and biosimilars. The inspection confirmed that the site is compliant with GMP guidelines and no Form 483 was issued.

Sartorius Stedim Biotech purchased BioOutsource in 2015, and a full-year financial results report stated the company had a positive impact on Sartorius’ 16% increase in group sales revenue. The company noted that the acquisition of BioOutsource and Cellca GmbH had an impact on sales, “contributing nearly two percentage points in constant currencies to the divisions sales expansion.”

Source: Sartorius Stedim Biotech

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More